ABL1 | C-abl oncogene 1, non-receptor tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
ABL2 | C-abl oncogene 2, non-receptor tyrosine kinase | Cancer-related genes Enzymes RAS pathway related proteins
| | | | | Expressed in all |
AKT1 | V-akt murine thymoma viral oncogene homolog 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
AKT3 | V-akt murine thymoma viral oncogene homolog 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
BAD | BCL2-associated agonist of cell death | Cancer-related genes Mitochondrial proteins RAS pathway related proteins
| | | | | Expressed in all |
BCL2L1 | BCL2-like 1 | Cancer-related genes Mitochondrial proteins Predicted membrane proteins RAS pathway related proteins Transporters
| | | | | Expressed in all |
BRAP | BRCA1 associated protein | RAS pathway related proteins
| | | | | Expressed in all |
CDC42 | Cell division cycle 42 | Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
CHUK | Conserved helix-loop-helix ubiquitous kinase | Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
ELK1 | ELK1, member of ETS oncogene family | RAS pathway related proteins Transcription factors
| | | | | Expressed in all |
ETS1 | V-ets avian erythroblastosis virus E26 oncogene homolog 1 | Plasma proteins RAS pathway related proteins Transcription factors
| | | | | Expressed in all |
EXOC2 | Exocyst complex component 2 | RAS pathway related proteins
| | | | | Expressed in all |
FGF1 | Fibroblast growth factor 1 (acidic) | Cancer-related genes FDA approved drug targets RAS pathway related proteins
| | | | | Group enriched |
FGF13 | Fibroblast growth factor 13 | RAS pathway related proteins
| | | | | Mixed |
FGF2 | Fibroblast growth factor 2 (basic) | Cancer-related genes Candidate cardiovascular disease genes FDA approved drug targets RAS pathway related proteins
| | | | | Mixed |
FGF5 | Fibroblast growth factor 5 | Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FGFR2 | Fibroblast growth factor receptor 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
FLT4 | Fms-related tyrosine kinase 4 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
FOXO4 | Forkhead box O4 | Cancer-related genes Disease related genes RAS pathway related proteins Transcription factors
| | | | | Tissue enriched |
GRB2 | Growth factor receptor-bound protein 2 | Cancer-related genes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
IKBKB | Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | Disease related genes Enzymes FDA approved drug targets Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
IKBKG | Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | Disease related genes RAS pathway related proteins
| | | | | Expressed in all |
INSR | Insulin receptor | CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Expressed in all |
MAP2K1 | Mitogen-activated protein kinase kinase 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
MAP2K2 | Mitogen-activated protein kinase kinase 2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
MAPK1 | Mitogen-activated protein kinase 1 | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
MAPK3 | Mitogen-activated protein kinase 3 | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
MET | Met proto-oncogene | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
MLLT4 | Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | Cancer-related genes Disease related genes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
NFKB1 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | Cancer-related genes FDA approved drug targets Plasma proteins RAS pathway related proteins Transcription factors
| | | | | Expressed in all |
PAK1 | P21 protein (Cdc42/Rac)-activated kinase 1 | Enzymes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
PAK2 | P21 protein (Cdc42/Rac)-activated kinase 2 | Enzymes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
PDGFC | Platelet derived growth factor C | Predicted secreted proteins RAS pathway related proteins
| | | | | Expressed in all |
PLA2G4A | Phospholipase A2, group IVA (cytosolic, calcium-dependent) | Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Mixed |
PLCE1 | Phospholipase C, epsilon 1 | Disease related genes Enzymes Plasma proteins Potential drug targets RAS pathway related proteins
| | | | | Mixed |
PLCG1 | Phospholipase C, gamma 1 | Cancer-related genes Enzymes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
PRKCA | Protein kinase C, alpha | Cancer-related genes Enzymes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
PRKX | Protein kinase, X-linked | Disease related genes Enzymes Plasma proteins Potential drug targets RAS pathway related proteins
| | | | | Mixed |
RAB5C | RAB5C, member RAS oncogene family | Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
RASGRF1 | Ras protein-specific guanine nucleotide-releasing factor 1 | RAS pathway related proteins
| | | | | Group enriched |
RELA | V-rel avian reticuloendotheliosis viral oncogene homolog A | Cancer-related genes Disease related genes RAS pathway related proteins Transcription factors
| | | | | Expressed in all |
RHOA | Ras homolog family member A | Cancer-related genes Cytoskeleton related proteins RAS pathway related proteins
| | | | | Expressed in all |
SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | Mitochondrial proteins RAS pathway related proteins
| | | | | Expressed in all |
SOS2 | Son of sevenless homolog 2 (Drosophila) | Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
STK4 | Serine/threonine kinase 4 | Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
VEGFA | Vascular endothelial growth factor A | Cancer-related genes Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Expressed in all |